Professor
Tata Memorial Centre, India
Dr. Jyoti Bajpai is currently working as the Professor of Medical Oncology, at Tata Memorial Centre, Mumbai, India. Her oncology training involved All India Institute of Medical Sciences (AIIMS), Delhi(DM oncology), India and Memorial Sloan catering cancer Center, New York and Johns Hopkins Cancer Center, Baltimore, Maryland, USA ( observerships in “Immuno-Oncology -Melanoma” and in “Sarcomas”)
SERVICE:
• Core areas : Immuno-oncology, Breast cancer and Bone , Soft Tissue and Skin malignancies
• Specific interests : Immuno-Oncology, Rare Cancers (including ultra-rare sarcomas , Pregnancy associated cancers, Melanomas) , Adolescents and Young adult Cancer s(AYA), Precision Medicine
LEADERSHIP POSITIONS: INTERNATIONAL :
• European Society for Medical Oncology (ESMO) ,Women for Oncology committee –Core Member , 2020-2022
• ESMO faculty member for Sarcoma (immediate past)
• ESMO faculty member for Immunotherapy •
• Invited International advisory board member -WOMEN FOR ONCOLOGY -: Hong Kong Women for Oncology committee (HKW4O) , EgyptW4 O group
• Mentor -European Society for Medical Oncology (ESMO) leadership generation programme
NATIONAL:
• Founder and Current (2020)General Secretary: Immuno-Oncology Society of India (IOSI)
• Joint secretary –Indian Society of medical and Pediatric Oncology (ISMPO), Teenage and young adult foundation(TYAcan)
• Founding Chair of Women in oncology –India
Editorial positions:
• Journal of Immunotherapy and Precision Oncology
• Frontiers in oncology
• IJMPO
• (SAJC).
RESEARCH INTEREST
Dr. Bajpai is a keen researcher with 192 publications to her credit, including several original articles in high impact journals and part of several multinational projects .
Specific Areas:
• International Guidelines development:
• Low cost sustainable care applicable to LMICS – novel “OGS-12” protocol development for osteosarcoma
• Innovative technology to Country –QOL issues- Scalp Cooling For Chemo Induced alopecia prevention- established the practice in India and Institute
• Immuno-oncology
• Rare cancers
• Women–for-oncology
• Prognostication
• Novel therapies, drug repositioning